Impact of Astaxanthin on Cognition in Recreationally Active Females

NCT06460181 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-06-14

No results posted yet for this study

Summary

The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.

Conditions

  • Mental Fatigue

Interventions

DIETARY_SUPPLEMENT

Astaxanthin

Manufactured by AstaReal Inc

DIETARY_SUPPLEMENT

Placebo

Manufactured by AstaReal Inc

Sponsors & Collaborators

  • University of North Alabama

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-11-01
Completion
2024-11-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06460181 on ClinicalTrials.gov